Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Manuela Vicari"'
Autor:
Francesco Fontana, Marco Delsante, Manuela Vicari, Chiara Pala, Gaetano Alfano, Silvia Giovanella, Giulia Ligabue, Marco Leonelli, Lucio Manenti, Giovanni Maria Rossi, Riccardo Magistroni, Enrico Fiaccadori, Gabriele Donati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617a6542525104433380896ce7cab96e
https://hdl.handle.net/11380/1306308
https://hdl.handle.net/11380/1306308
Autor:
Bolognani, Cláudia Vicari, Imoto, Aline Mizusaki, Amorim, Fabio Ferreira, Duarte, Márcio Luis, Bolognani, Manuela Vicari, Da Silva, Claudia Cardoso Gomes, Fernandes, Sérgio Eduardo Soares
To present a scoping review protocol that aims to identify the evidence in the scientific literature on the application of AAI practices, regardless of the region, place of application, health condition of the population, time of application and form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1d56bf75ce8a98603fc255b20707de1
Autor:
Françoise Damnon, Isabelle Surbeck, Maryse Fiche, Chahin Achtari, Ilaria Gori, Manuela Vicari, Geraldine O. Canny, Rajesh Kumar
Publikováno v:
Journal of reproductive immunology
Immunity and hormonal responses in the reproductive tissues of postmenopausal women are poorly understood. Secretory leukocyte protease inhibitor (SLPI), a multifunctional antimicrobial protein expressed at mucosal surfaces, is thought to play a key
Autor:
Stefano Ongarello, Ulrike Gnad-Vogt, Magali Joffraud, Cristiana Sessa, Aurelius Omlin, Joachim Beck, Silke Gillessen, Caroline Bertrand, Roger Stupp, Manuela Vicari, Daniel E. Speiser, Bernd Liedert, Sonia Quaratino, Julien Laurent, Elisa Gallerani, Cédric Touvrey
Publikováno v:
Journal of Translational Medicine, vol. 11, no. 5, pp. 1-12
Journal of Translational Medicine
Journal of Translational Medicine, Vol 11, Iss 1, p 5 (2013)
Journal of Translational Medicine
Journal of Translational Medicine, Vol 11, Iss 1, p 5 (2013)
Background EMD 521873 (Selectikine or NHS-IL2LT) is a fusion protein consisting of modified human IL-2 which binds specifically to the high-affinity IL-2 receptor, and an antibody specific for both single- and double-stranded DNA, designed to facilit
Autor:
Verena Voelter, Pedro Romero, Serge Leyvraz, Manuela Vicari, Cédric Touvrey, Anne Papaioannou, Victor Appay, Giorgia Canellini, Daniel E. Speiser, Nathalie Rufer, Julien Laurent, Donata Rimoldi
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 33(7)
Recent immunotherapy trials have shown that lymphodepletion induced by short-term chemotherapy favors subsequent expansion of adoptively transferred T cells, by homeostatic mechanisms. To take advantage of this effect, novel regimens are being develo